Scott Gettinger
MD
Professor of Medicine (Oncology)
👥Biography 个人简介
Dr. Scott Gettinger at Yale has been a lead investigator in seminal immunotherapy trials for non-small cell lung cancer, including early nivolumab studies. He has contributed significantly to understanding PD-L1 expression as a predictive biomarker and has investigated mechanisms of primary and acquired resistance to checkpoint inhibitors in thoracic oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Scott Gettinger 的研究动态
Follow Scott Gettinger's research updates
留下邮箱，当我们发布与 Scott Gettinger（Yale School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment